In this article, Pamela James, PhD, Vice President, Product, provides a basic overview of the fundamentals of glycobiology and its role in health and disease, reviews the characteristics that make glycans and glycosylation strong potential candidates for biomarker discovery, and discusses the latest advances in research methods powering new applications for glycobiology.
Leveraging Glycobiology for Biomarker Discovery
